Article
Risk assessment for epithelial ovarian cancer: proposing a new approach to a deadly problem.
Scandinavian journal of clinical and laboratory investigation. Supplementum - 1 Jan 2014
Chu Mary M, Fishman David
Abstract excerpt
Presently the majority of women diagnosed with epithelial ovarian cancer (EOC) have advanced stage disease (III-IV) with a poor 5-year survival rate (12-30 %). This significantly contrasts when early stage disease is detected, which has a 5-year survival rate approximating 90 %. Therefore, detection of early stage disease is critical to making an impact on outcome. By using genetic algorithms, modifications of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
